Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

CDXC ChromaDex Corporation

5,81
-0,14 (-2,35%)
28 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Form 4 - Statement of changes in beneficial ownership of securities
="/themes/custom/secgov/images/sec-logo.png" alt="SEC Emblem" />

Oops! Page Not Found.


Error 404

Please check the web address or try searching below.

To report a broken link, please email webmaster@sec.gov.
We regret any inconvenience and we thank you for your interest in the SEC website.

Return to Top

 

Exhibit 99.1

 

FORM 4 JOINT FILER INFORMATION

 

Names of Joint Filers:

 

Li Ka Shing

Prime Tech Global Limited

Mayspin Management Limited

 

Address of Joint Filers:

 

C/O 7/F, CHEUNG KONG CENTER,

2 QUEEN'S ROAD, CENTRAL,

HONG KONG

 

Designated Filer:

 

Li Ka Shing

 

Issuer and Ticker Symbol:

 

ChromaDex Corporation [CDXC]

 

Date of Event:

 

August 20, 2024

 

Signatures of Joint Filers:

 

Li Ka Shing

By: /s/ Li Ka Shing

---------------

 

Prime Tech Global Limited

By: /s/ Pau Yee Wan Ezra

--------------------

 

Mayspin Management Limited

By: /s/ Pau Yee Wan Ezra

--------------------

 

 



 

Exhibit 99.1

 

FORM 4 JOINT FILER INFORMATION

 

Names of Joint Filers:

 

Li Ka Shing

Prime Tech Global Limited

Mayspin Management Limited

 

Address of Joint Filers:

 

C/O 7/F, CHEUNG KONG CENTER,

2 QUEEN'S ROAD, CENTRAL,

HONG KONG

 

Designated Filer:

 

Li Ka Shing

 

Issuer and Ticker Symbol:

 

ChromaDex Corporation [CDXC]

 

Date of Event:

 

August 20, 2024

 

Signatures of Joint Filers:

 

Li Ka Shing

By: /s/ Li Ka Shing

---------------

 

Prime Tech Global Limited

By: /s/ Pau Yee Wan Ezra

--------------------

 

Mayspin Management Limited

By: /s/ Pau Yee Wan Ezra

--------------------

 

 



Grafico Azioni ChromaDex (NASDAQ:CDXC)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di ChromaDex
Grafico Azioni ChromaDex (NASDAQ:CDXC)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di ChromaDex

Notizie ChromaDex Corporation - CDXC

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Lunedì 6 Gennaio 2025 (3 settimane fa) • Business Wire
Form 8-K - Current report
Lunedì 16 Dicembre 2024 (1 mese fa) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Sabatp 14 Dicembre 2024 (1 mese fa) • Edgar (US Regulatory)
Form 144 - Report of proposed sale of securities
Venerdì 13 Dicembre 2024 (1 mese fa) • Edgar (US Regulatory)
Form 8-K - Current report
Mercoledì 4 Dicembre 2024 (2 mesi fa) • Edgar (US Regulatory)
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
Martedì 3 Dicembre 2024 (2 mesi fa) • Business Wire
Form 4 - Statement of changes in beneficial ownership of securities
Lunedì 25 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)
Form 424B3 - Prospectus [Rule 424(b)(3)]
Giovedì 21 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)
Form 8-K - Current report
Giovedì 21 Novembre 2024 (2 mesi fa) • Edgar (US Regulatory)
ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement
Giovedì 14 Novembre 2024 (2 mesi fa) • Business Wire
Form 3 - Initial statement of beneficial ownership of securities
Venerdì 8 Novembre 2024 (3 mesi fa) • Edgar (US Regulatory)
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
Giovedì 7 Novembre 2024 (3 mesi fa) • Business Wire

Più ChromaDex Corporation Articoli Notizie

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network